Device-related infection and mortality in patients with chronic kidney disease receiving cardiac implantable electronic devices: a propensity score-matched cohort study. Posted on December 5th, 2023 by LEADconnection Post navigation Previous: PROFID EHRA trial enrols first patientNext: Practical Considerations for Cardiac Electronic Devices Reimplantation Following Transvenous Lead Extraction Due to Related Endocarditis.
Imaging in patients with cardiovascular implantable electronic devices – Part 1: Imaging before and during device implantation. Posted on November 8th, 2023 by LEADconnection Post navigation Previous: Feasibility of Ultrasound-Guided Axillary Vein Puncture under Valsalva Maneuver for Diagnostic and Cardiovascular Interventional Purposes: Pacemaker and Cardioverter-Defibrillator Implantation.Next: Cardiac resynchronization therapy from an iliac approach in a patient without superior access: a case report.
Feasibility of Ultrasound-Guided Axillary Vein Puncture under Valsalva Maneuver for Diagnostic and Cardiovascular Interventional Purposes: Pacemaker and Cardioverter-Defibrillator Implantation. Posted on November 8th, 2023 by LEADconnection Post navigation Previous: Long-term follow-up of selective and non-selective His bundle pacing leads in patients with atrioventricular block.Next: Imaging in patients with cardiovascular implantable electronic devices – Part 1: Imaging before and during device implantation.
